MLSS Stock Overview
A biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Milestone Scientific Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.65 |
| 52 Week High | US$1.10 |
| 52 Week Low | US$0.52 |
| Beta | 1.08 |
| 11 Month Change | -24.15% |
| 3 Month Change | -31.86% |
| 1 Year Change | -19.12% |
| 33 Year Change | -75.47% |
| 5 Year Change | -43.48% |
| Change since IPO | -95.44% |
Recent News & Updates
Shareholder Returns
| MLSS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -14.2% | -1.1% | -2.1% |
| 1Y | -19.1% | 22.8% | 30.2% |
Return vs Industry: MLSS underperformed the US Medical Equipment industry which returned 22.8% over the past year.
Return vs Market: MLSS underperformed the US Market which returned 30.2% over the past year.
Price Volatility
| MLSS volatility | |
|---|---|
| MLSS Average Weekly Movement | 9.5% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MLSS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: MLSS's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 17 | Arjan Haverhals | www.milestonescientific.com |
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.
Milestone Scientific Inc. Fundamentals Summary
| MLSS fundamental statistics | |
|---|---|
| Market cap | US$50.24m |
| Earnings (TTM) | -US$4.62m |
| Revenue (TTM) | US$8.88m |
5.7x
P/S Ratio-10.9x
P/E RatioIs MLSS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLSS income statement (TTM) | |
|---|---|
| Revenue | US$8.88m |
| Cost of Revenue | US$2.44m |
| Gross Profit | US$6.43m |
| Other Expenses | US$11.05m |
| Earnings | -US$4.62m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.06 |
| Gross Margin | 72.48% |
| Net Profit Margin | -52.01% |
| Debt/Equity Ratio | 0% |
How did MLSS perform over the long term?
See historical performance and comparison